Tech Company Financing Transactions
TRACON Pharmaceuticals Funding Round
On 4/11/2018, TRACON Pharmaceuticals raised $38.7 million in investment from private investors.
Transaction Overview
Company Name
Announced On
4/11/2018
Transaction Type
Venture Equity
Amount
$38,673,734
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 11 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
4350 La Jolla Village Dr. 800
San Diego, CA 92122
USA
San Diego, CA 92122
USA
Phone
Website
Email Address
Overview
TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) is a biotechnology company developing next-generation targeted therapies for cancer and related diseases. We are addressing unmet needs in this arena with product candidates that focus on cellular targets specifically implicated in cancer growth and angiogenesis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charles Theuer
Vice President
Jennifer Ellis
VP - Operations
Bonne Adams
VP - Product Management
Sharon Real
VP - Regulatory Affairs
Suzy Benedict
Browse more venture capital transactions:
Prev: 4/11/2018: Genie Enterprise venture capital transaction
Next: 4/11/2018: Fleetsmith venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs